AEterna Zentaris Inc (NASDAQ:AEZS)

1.86
Delayed Data
As of 4:00pm ET
 -0.02 / -1.06%
Today’s Change
0.78
Today|||52-Week Range
3.75
-21.19%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close1.88
Today’s open1.88
Day’s range1.86 - 1.92
Volume63,198
Average volume (3 months)663,021
Market cap$30.8M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+86.71%
Earnings growth (this year)+40.19%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+67.16%
P/E ratioNM
Price/Sales42.25
Price/Book3.95

Competitors

 Today’s
change
Today’s
% change
PRTOProteon Therapeutics...+0.15+6.98%
IMMPImmutep Ltd+0.06+3.47%
FSIFlexible Solutions I...-0.03-1.80%
HTGMHTG Molecular Diagno...-0.35-6.82%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$911.0K
Annual profit (last year)-$25.0M
Net profit margin-2,739.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Michael Ward
Vice President-
Pre-Clinical Development
Michael Teifel
Corporate headquarters
Montréal, Qubec

Forecasts